福利姬

Since 2022, the Wallenberg Center for Molecular Medicine (WCMM) at LiU goes on a yearly Retreat where WCMM affiliates engage in group activities. Look at our programs, ideas, and pictures!

WCMM at LiU focuses on the medicine-technology interface, and build upon our existing strengths in research within medical technology, materials science and bioengineering.

PROtein folding and Ligand INteraction Core facility (ProLinC) at 福利姬.

A fundamental shift in early medical device development that replaces animal testing with physical proxies that are constructed specifically to mimic human tissue over a range of pathological states.

The design and development of low-cost, handheld devices toward seamless integration in to clinical practice, reducing translational barriers novel technologies and methods

We develop methods and instrumentation that advance spectroscopy, light transport modeling, and imaging of tissue; creating quantitative, non-invasive tools for the clinical detection, monitoring or treatment of skin diseases and injuries.

The Wallenberg Centre for Molecular Medicine (WCMM) at LiU has been granted extended funding until 2039 by the Knut and Alice Wallenberg Foundation. This makes it possible to build on ten years of success and to recruit new physician-scientists.

On 8-9 december 2025, it was once again time to bring together the WCMM/DDLS affiliates for a retreat.

Welcome to the fourth Wallenberg Center for Molecular Medicine, WCMM, Symposium on 21-22 April 2022 in Linköping. Registration, program and more information is now available!

Cancer cells with a cell nucleus that is easily deformed are more sensitive to drugs that damage DNA, shows a new study. The results may also explain why combining certain cancer drugs can produce the opposite of the intended effect.